40 companies

Fine Foods & Pharmaceuticals N.T.M

Market Cap: €193.8m

Fine Foods & Pharmaceuticals N.T.M. S.p.A.

FF

€8.28

7D

0.2%

1Y

-1.4%

Natera

Market Cap: US$39.3b

A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.

New

NTRA

US$274.62

7D

1.8%

1Y

94.7%

Diaceutics

Market Cap: UK£122.8m

A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.

DXRX

UK£1.50

7D

9.5%

1Y

8.7%

CanSino Biologics

Market Cap: HK$9.7b

Develops, manufactures, and commercializes vaccines in the People’s Republic of China.

6185

HK$23.00

7D

-0.8%

1Y

-53.9%

Mesoblast

Market Cap: AU$2.9b

Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.

MSB

AU$2.23

7D

9.3%

1Y

-5.5%

InSilico Medicine Cayman TopCo

Market Cap: HK$23.5b

Engages in applying artificial intelligence (AI) solutions to drug discovery and development by leveraging its proprietary platforms.

3696

HK$40.98

7D

-2.6%

1Y

n/a

Cronos Group

Market Cap: CA$1.4b

A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.

New

CRON

CA$4.32

7D

6.4%

1Y

38.9%

AstraZeneca

Market Cap: UK£186.7b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

AZN

UK£118.50

7D

-6.8%

1Y

8.2%

CSPC Innovation Pharmaceutical

Market Cap: CN¥55.7b

Engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally.

300765

CN¥40.00

7D

11.1%

1Y

-18.4%

Laboratorios Farmaceuticos Rovi

Market Cap: €3.0b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

ROVI

€58.60

7D

-1.1%

1Y

10.4%

Sichuan Kelun-Biotech Biopharmaceutical

Market Cap: HK$121.4b

A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, metabolism, and other therapeutic areas in the People’s Republic of China and internationally.

New

6990

HK$508.00

7D

5.6%

1Y

27.1%

Teva Pharmaceutical Industries

Market Cap: US$40.5b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

TEVA

US$34.81

7D

-1.7%

1Y

113.7%

Medexus Pharmaceuticals

Market Cap: CA$157.4m

Operates as a pharmaceutical company in Canada and the United States.

MDP

CA$4.98

7D

2.0%

1Y

82.4%

Akeso

Market Cap: HK$88.5b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.

9926

HK$96.05

7D

3.1%

1Y

-39.0%

Innovent Biologics

Market Cap: HK$158.3b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.

New

1801

HK$90.95

7D

3.2%

1Y

-0.5%

Pangaea Oncology

Market Cap: €55.7m

A precision oncology company, provides a range of services to cancer patients in Spain and the rest of European Union countries.

PANG

€1.55

7D

0%

1Y

-9.9%

Renata

Market Cap: ৳54.3b

Manufactures, markets, and distributes pharmaceuticals, animal health medicines, oncology-based, agro-based, poultry, and consumer products in Bangladesh.

RENATA

৳472.40

7D

0.5%

1Y

-5.6%

Aroa Biosurgery

Market Cap: AU$195.4m

Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.

ARX

AU$0.56

7D

0%

1Y

-7.4%

Chugai Pharmaceutical

Market Cap: JP¥11.1t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

4519

JP¥6,764.00

7D

-4.3%

1Y

-8.6%

Recordati Industria Chimica e Farmaceutica

Market Cap: €10.7b

Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.

REC

€52.65

7D

2.2%

1Y

4.8%

Biocytogen Pharmaceuticals (Beijing)

Market Cap: HK$50.9b

A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.

2315

HK$55.55

7D

15.3%

1Y

126.0%

Galderma Group

Market Cap: CHF 41.6b

Operates as a dermatology company worldwide.

GALD

CHF 178.25

7D

-1.3%

1Y

36.7%

Merck

Market Cap: US$317.0b

Operates as a healthcare company worldwide.

MRK

US$128.37

7D

-1.1%

1Y

59.7%

Caliway Biopharmaceuticals

Market Cap: NT$167.3b

Engages in the development of drugs for aesthetic medicine and chronic inflammation.

6919

NT$107.50

7D

4.4%

1Y

-17.3%

AbbVie

Market Cap: US$435.1b

A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.

New

ABBV

US$246.20

7D

-4.4%

1Y

23.8%

WuXi XDC Cayman

Market Cap: HK$70.2b

An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.

2268

HK$55.40

7D

8.5%

1Y

-3.5%

BioGaia

Market Cap: SEK 11.4b

A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

BIOG B

SEK 111.70

7D

-3.5%

1Y

17.7%

AcrobiosystemsLtd

Market Cap: CN¥9.0b

Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and research institutions.

301080

CN¥53.96

7D

13.6%

1Y

-0.02%

hVIVO

Market Cap: UK£47.7m

Operates as a full-service early specialist contract research organisation in the United Kingdom, Europe, and North America.

HVO

UK£0.069

7D

-11.0%

1Y

-32.7%

SIGA Technologies

Market Cap: US$232.4m

A commercial-stage pharmaceutical company, focuses on the health security market in the United States.

SIGA

US$3.15

7D

-5.7%

1Y

-56.6%

Sotera Health

Market Cap: US$5.1b

Provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.

SHC

US$18.91

7D

5.9%

1Y

68.5%

Selvita

Market Cap: zł514.0m

Provides drug discovery, drug development, and contract testing services in Poland.

SLV

zł27.95

7D

5.3%

1Y

-17.3%

Mesa Laboratories

Market Cap: US$566.0m

Develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.

MLAB

US$102.62

7D

3.0%

1Y

65.5%

Ligand Pharmaceuticals

Market Cap: US$6.0b

A biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.

LGND

US$302.57

7D

5.1%

1Y

112.5%

ALK-Abelló

Market Cap: DKK 49.1b

An allergy solutions company, develops treatments for respiratory allergy, anaphylaxis, and food allergy and new disease areas in the European Union, the United Kingdom, Norway, Switzerland, the United States, Canada, Japan, China, and internationally.

ALK B

DKK 220.60

7D

-2.8%

1Y

19.2%

Strides Pharma Science

Market Cap: ₹91.9b

A pharmaceutical company, engages in the development, manufacturing, and marketing of pharmaceutical products in North America, Australia, Africa, Europe, India, the rest of Asia, and internationally.

STAR

₹997.20

7D

-7.0%

1Y

24.9%

Page 1 of 2